Join
Live feed
·
INSIDERFilingvia Quantisnow
INVO BioScience Inc. logo

SEC Form 4: Szot Matthew K bought $13,750 worth of shares (14,474 units at $0.95), increasing direct ownership by 59% to 39,175 units

ByQuantisnow·Wall Street's wire, on your screen.
INVO· INVO BioScience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INVO (INVO BioScience Inc.) and more on Quantisnow.